Literature DB >> 23246926

Cerebral white matter injury and damage to myelin sheath following whole-brain ischemia.

Yingzhu Chen1, Qiong Yi, Gang Liu, Xue Shen, Lihui Xuan, Ye Tian.   

Abstract

Myelin sheath, either in white matter or in other regions of brain, is vulnerable to ischemia. The specific events involved in the progression of ischemia in white matter have not yet been elucidated. The aim of this study was to determine histopathological alterations in cerebral white matter and levels of myelin basic protein (MBP) in ischemia-injured brain tissue during the acute and subacute phases of central nervous injury following whole-brain ischemia. The whole cerebral ischemia model (four-vessel occlusion (4-VO)) was established in adult Sprague-Dawley rats and MBP gene expression and protein levels in the brain tissue were measured using reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) at 2 days, 4 days, 7 days, 14 days, and 28 days following ischemia. Demyelination was determined by Luxol fast blue myelin staining, routine histopathological staining, and electron microscopy in injured brain tissue. Results showed that edema, vascular dilation, focal necrosis, demyelination, adjacent reactive gliosis and inflammation occurred 7 days after ischemia in HE staining and recovered to control levels at 28 days. The absence of Luxol fast blue staining and vacuolation was clearly visible at 7 days, 14 days, and 28 days. Semiquantitative analysis showed that the transparency of myelin had decreased significantly by 7 days, 14 days, and 28 days. Demyelination and ultrastructual changes were detected 7 days after ischemia. The relative levels of MBP mRNA decreased 2 days after ischemia and this trend continued throughout the remaining four points in time. The MBP levels measured using ELISA also decreased significantly at 2 days and 4 days, but they recovered by 7 days and returned to control levels by 14 days. These results suggest that the impact of ischemia on cerebral white matter is time-sensitive and that different effects may follow different courses over time.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246926     DOI: 10.1016/j.brainres.2012.12.006

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Transneuronal Degeneration of Thalamic Nuclei following Middle Cerebral Artery Occlusion in Rats.

Authors:  Shu-Jen Chang; Juin-Hong Cherng; Ding-Han Wang; Shu-Ping Yu; Nien-Hsien Liou; Ming-Lun Hsu
Journal:  Biomed Res Int       Date:  2016-08-11       Impact factor: 3.411

2.  Effects of Erythropoietin on Gliogenesis during Cerebral Ischemic/Reperfusion Recovery in Adult Mice.

Authors:  Rongliang Wang; Jincheng Li; Yunxia Duan; Zhen Tao; Haiping Zhao; Yumin Luo
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

3.  Effects of prenatal photobiomodulation treatment on neonatal hypoxic ischemia in rat offspring.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Hannah Youngblood; Yong Li; Xuemei Zong; Lei Li; Tongda Xu; Quanguang Zhang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

4.  The neuroprotective effect of picroside II via regulating the expression of myelin basic protein after cerebral ischemia injury in rats.

Authors:  Li Zhao; Yunliang Guo; Xiaojun Ji; Meizeng Zhang
Journal:  BMC Neurosci       Date:  2014-02-14       Impact factor: 3.288

5.  Proteomic profiles in cerebrospinal fluid predicted death and disability in term infants with perinatal asphyxia: A pilot study.

Authors:  Kristin Leifsdottir; Eric P Thelin; Philipp Lassarén; Veronica Siljehav; Peter Nilsson; Staffan Eksborg; Eric Herlenius
Journal:  Acta Paediatr       Date:  2022-02-17       Impact factor: 4.056

6.  Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration.

Authors:  Vasileios Alexandros Karakousis; Danai Liouliou; Aikaterini Loula; Nikoleta Kagianni; Eva-Maria Dietrich; Soultana Meditskou; Antonia Sioga; Theodora Papamitsou
Journal:  Medicina (Kaunas)       Date:  2020-03-19       Impact factor: 2.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.